Treatment of Central Nervous System Disorders by Use of PDGF or VEGF

Details for Australian Patent Application No. 2006203260 (hide)

Owner NeuroNova AB

Inventors Janson, Ann Marie; Wachs, FrankPeter; Plate, Karlheinz; Delfani, Kioumars; Zhao, Ming; Schanzer, Anne; Kuhn, Georg H.

Agent Cullen & Co

Pub. Number AU-B-2006203260

Parent 2002334327

Filing date 31 July 2006

Wipo publication date 24 August 2006

Acceptance publication date 4 December 2008

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

17 August 2006 Complete Application Filed

24 August 2006 Application Open to Public Inspection

  Published as AU-B-2006203260

4 December 2008 Application Accepted

  Published as AU-B-2006203260

2 April 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006203261-A Safety Handrail System for Scaffolding Planks

2006203259-Method and cradle to handle a stator bar